Clinical Utility of Hana(r) Orthopedic Table Highlighted in New Study: 97% of Direct Anterior Approach Hip Replacement Patients Needed Little to No Opioid Pain Medication After Surgery

This post was originally published on this site

Original post: August 24, 2020 9:00 am Newswise - Drug and Drug Abuse Clinical Utility of Hana(r) Orthopedic Table Highlighted in New Study: 97% of Direct Anterior Approach Hip Replacement Patients Needed Little to No Opioid Pain Medication After Surgery

Mizuho OSI(r), a leading manufacturer of specialty surgical tables and pressure injury abatement solutions would like to announce the publication of a new clinical study titled “23-hour Total Hip Replacement Requiring Only 3.5 Opioid Pills Through 6 Weeks: A Non-selected Prospective Consecutive One Year Cohort”, by Andrew Wickline MD, now appearing in the peer-reviewed Journal of Orthopedic Experience & Innovation (JournalOEI)